SCHEMBL7989405

SCHEMBL7989405

CCCc1nc2ncn(Cc3ccccc3)c2c(=O)[nH]1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.57
ALDH1A1 P00352 2/20 0.57
HPGD P15428 1/20 0.57
KMT2A Q03164 2/20 0.56
BRD4 O60885 1/20 0.49
PNP P00491 2/20 0.44
PARN O95453 1/20 0.44
CNOT7 Q9UIV1 1/20 0.44
GAA P10253 1/20 0.43
ADORA2B P29275 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 2/20 0.42
HIF1A Q16665 1/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987608 0.93 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7989564 0.92 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7975251 0.90 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7989373 0.89 HPGD (0.46) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7974253 0.89 HPGD (0.46) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7985079 0.89 KDM4E (0.49) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7991723 0.89 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7988953 0.88 HPGD (0.45) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7985634 0.88 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7985729 0.88 HPGD (0.50) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed